Well Lead Medical Co., Ltd.

SHSE:603309 Stock Report

Market Cap: CN¥3.6b

Well Lead Medical Management

Management criteria checks 3/4

Well Lead Medical's CEO is Guangyuan Han, appointed in Jun 2011, has a tenure of 13.5 years. directly owns 0.026% of the company’s shares, worth CN¥964.79K. The average tenure of the management team and the board of directors is 5.1 years and 13.5 years respectively.

Key information

Guangyuan Han

Chief executive officer

CN¥1.1m

Total compensation

CEO salary percentagen/a
CEO tenure13.5yrs
CEO ownership0.03%
Management average tenure5.1yrs
Board average tenure13.5yrs

Recent management updates

Recent updates

Calculating The Fair Value Of Well Lead Medical Co., Ltd. (SHSE:603309)

Sep 30
Calculating The Fair Value Of Well Lead Medical Co., Ltd. (SHSE:603309)

Well Lead Medical's (SHSE:603309) Solid Profits Have Weak Fundamentals

Aug 02
Well Lead Medical's (SHSE:603309) Solid Profits Have Weak Fundamentals

CEO

Guangyuan Han (60 yo)

13.5yrs

Tenure

CN¥1,102,000

Compensation

Mr. Guangyuan Han serves as Vice Chairman and General Manager at Well Lead Medical Co., Ltd. since June 9, 2011.


Leadership Team

NamePositionTenureCompensationOwnership
Guangyuan Han
Vice Chairman & GM13.5yrsCN¥1.10m0.026%
CN¥ 964.8k
Yimin Zhu
CFO & Accounting Supervisor3.7yrsCN¥1.01m0.027%
CN¥ 996.1k
Yungui Chen
Deputy GM & Director6.6yrsCN¥1.36m0.041%
CN¥ 1.5m
Bin Chen
Deputy GM & Board Secretary3.2yrsCN¥1.25m0.033%
CN¥ 1.2m

5.1yrs

Average Tenure

46.5yo

Average Age

Experienced Management: 603309's management team is seasoned and experienced (5.1 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Guangyuan Han
Vice Chairman & GM13.5yrsCN¥1.10m0.026%
CN¥ 964.8k
Yungui Chen
Deputy GM & Director4.3yrsCN¥1.36m0.041%
CN¥ 1.5m
Xiang Bin
Chairman of the Board13.5yrsCN¥1.24m0.033%
CN¥ 1.2m

13.5yrs

Average Tenure

55yo

Average Age

Experienced Board: 603309's board of directors are seasoned and experienced ( 13.5 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 02:46
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Well Lead Medical Co., Ltd. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jingning LongChasing Securities